Trial intelligence / Profile preview

Humoral Response to TBE Vaccine in Elderly

NCT01361776Phase 3Completed

Sponsor
Region Sörmland
Start
Sep 2011
Primary completion
Dec 2013
Modality
Whole Inactivated Vaccines
Countries
2
01

Overview

A Phase 3 trial of FSME-IMMUN in tick-borne encephalitis (TBE), sponsored by Region Sörmland. Started Sep 2011; status: completed.

02

Drugs

FSME-IMMUN
03

Conditions

tick-borne encephalitis (TBE)

Beyond the preview

Go deeper on NCT01361776.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01361776.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call